Fundraising FoxVironexis
4 known investors
Find your way into Vironexis
Sign up to find every way you can get introduced to Vironexis
- Your email: who you already know at Vironexis, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Vironexis team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Vironexis is a clinical-stage biotechnology company developing gene therapies that deliver vectorized T-cell engagers in a single IV dose through its in-vivo protein engineering approach. It is building a pipeline of more than 10 product candidates aimed at providing durable, T-cell-mediated cancer treatments.
Founders & leadership
Investors · 4
How we know: Capital Factory's portfolio page · funding news · Not right? Tell us
How we know: Drive Capital's portfolio page · funding news · Not right? Tell us
How we know: Moonshots Capital's portfolio page · funding news · the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Vironexis do?
- Vironexis is a clinical-stage biotechnology company developing gene therapies that deliver vectorized T-cell engagers in a single IV dose through its in-vivo protein engineering approach. It is building a pipeline of more than 10 product candidates aimed at providing durable, T-cell-mediated cancer treatments.
- Who founded Vironexis?
- Vironexis was founded by Timothy Cripe.
- Who are Vironexis's investors?
- Vironexis's investors include Capital Factory, Drive Capital, Moonshots Capital, Future Ventures.